Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10

Marcus Thuresson; Matthew A Cavender; Alex Z Fu; John P Wilding; Kamlesh Khunti; Reinhard W Holl; Anna Norhammar; Kåre I Birkeland; Marit Eika Jørgensen; Eric Wittbrodt; Niklas Hammar; Peter Fenici; Mikhail Kosiborod; CVD-REAL Investigators and Study Group

doi:10.2337/dc18-0338

Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10

Marcus Thuresson, Matthew A Cavender, Alex Z Fu, John P Wilding, Kamlesh Khunti, Reinhard W Holl, Anna Norhammar, Kåre I Birkeland, Marit Eika Jørgensen, Eric Wittbrodt, Niklas Hammar, Peter Fenici, Mikhail Kosiborod, CVD-REAL Investigators and Study Group

Steno Diabetes Center Copenhagen

9 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	International Journal of MS Care
Vol/bind	41
Udgave nummer	6
Sider (fra-til)	e106-e108
Antal sider	2
ISSN	1935-5548
DOI	https://doi.org/10.2337/dc18-0338
Status	Udgivet - jun. 2018

Adgang til dokumentet

10.2337/dc18-0338

Citationsformater

Thuresson, M., Cavender, M. A., Fu, A. Z., Wilding, J. P., Khunti, K., Holl, R. W., Norhammar, A., Birkeland, K. I., Jørgensen, M. E., Wittbrodt, E., Hammar, N., Fenici, P., Kosiborod, M., & CVD-REAL Investigators and Study Group (2018). Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10. International Journal of MS Care, 41(6), e106-e108. https://doi.org/10.2337/dc18-0338

Thuresson, M, Cavender, MA, Fu, AZ, Wilding, JP, Khunti, K, Holl, RW, Norhammar, A, Birkeland, KI, Jørgensen, ME, Wittbrodt, E, Hammar, N, Fenici, P, Kosiborod, M & CVD-REAL Investigators and Study Group 2018, 'Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10', International Journal of MS Care, bind 41, nr. 6, s. e106-e108. https://doi.org/10.2337/dc18-0338

@article{f0844d22ce494b5eb9980613b465d045,

title = "Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10",

keywords = "Letter",

author = "Marcus Thuresson and Cavender, {Matthew A} and Fu, {Alex Z} and Wilding, {John P} and Kamlesh Khunti and Holl, {Reinhard W} and Anna Norhammar and Birkeland, {K{\aa}re I} and J{\o}rgensen, {Marit Eika} and Eric Wittbrodt and Niklas Hammar and Peter Fenici and Mikhail Kosiborod and {CVD-REAL Investigators and Study Group}",

year = "2018",

month = jun,

doi = "10.2337/dc18-0338",

language = "English",

volume = "41",

pages = "e106--e108",

journal = "International Journal of MS Care",

issn = "1935-5548",

publisher = "American Diabetes Association",

number = "6",

}

TY - JOUR

T1 - Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies

T2 - Real or Bias? Diabetes Care 2018;41:6-10

AU - Thuresson, Marcus

AU - Cavender, Matthew A

AU - Fu, Alex Z

AU - Wilding, John P

AU - Khunti, Kamlesh

AU - Holl, Reinhard W

AU - Norhammar, Anna

AU - Birkeland, Kåre I

AU - Jørgensen, Marit Eika

AU - Wittbrodt, Eric

AU - Hammar, Niklas

AU - Fenici, Peter

AU - Kosiborod, Mikhail

AU - CVD-REAL Investigators and Study Group

PY - 2018/6

Y1 - 2018/6

KW - Letter

U2 - 10.2337/dc18-0338

DO - 10.2337/dc18-0338

M3 - Letter

C2 - 29784708

SN - 1935-5548

VL - 41

SP - e106-e108

JO - International Journal of MS Care

JF - International Journal of MS Care

IS - 6

ER -